Global Stem
Cell Cartilage Regeneration Market, by Stem Cell Type (Hematopoietic Stem
Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), by Treatment
(Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation,
and Others), by End User (Hospitals & Clinics and Ambulatory Surgical
Centers), and By Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) is estimated to be valued at US$ 298.3 million in
2019, and is expected to exhibit a CAGR of 9.1% over the forecast period
(2019-2027), as highlighted in a new report published by Coherent Market
Insights
Stem cell-based therapy is a key
focus in functional replacement of cartilage regeneration. Rising incidence of
osteoarthritis among the global population is expected to increase adoption of
efficient and promising treatment such as stem cell therapy during the forecast
period. There were 14 million individuals in the U.S. who has symptomatic knee
osteoarthritis and nearly 2 million people under the age of 45 that were
suffering from symptomatic knee osteoarthritis as per Arthritis Foundation,
2017.
Furthermore, growing engagement
of key players in developing stem cell therapy as commercially viable, safe,
efficient, and economical therapeutic agents for cartilage regeneration is
expected to drive growth of the global stem cell cartilage regeneration market
over the forecast period. For instance, organizations such as California’s Stem
Cell Agency is indulged in the development of new stem cell-based therapies for
chronic diseases such as cancer and rare diseases. Moreover, manufacturers such
as Sangamo Therapeutics and Fate Therapeutics are working on developing stem
cell-based therapies for diseases such as β-Thalassemia and cancer,
respectively.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2448
Furthermore, companies are also
focusing on research and development activities, in order to launch novel
products to increase their revenue in the stem cell cartilage regeneration
market. According to Alliance for Regenerative Medicine, globally there were
946 clinical trials in progress in 2017, an 18% increase over the previous
year.
Browse 32 Market Data Tables and
24 Figures spread through 154 Pages and in-depth TOC on “Global Stem Cell
Cartilage Regeneration Market"
Rising mergers and acquisitions
by major players to strengthen their share in this market is further expected
to drive growth of stem cell cartilage regeneration market. For instance, in
March 2015, Fujifilm Holding Corporation acquired Cellular Dynamics
International, Inc. (CDI). CDI’s technology platform enables the production of
high-quality fully functioning human cells, including induced pluripotent stem
cells (iPSCs), on an industrial scale, which will help the Fujifilm Holding
Corporation to strengthen their position in this segment.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/stem-cell-cartilage-regeneration-market-2448
Key Takeaways of the Global Stem
Cell Cartilage Regeneration Market:
The global stem cell cartilage
regeneration market is expected to exhibit a CAGR of 9.1% over the forecast
period (2019-2027), owing growing number of knee cartilage defects in patients
with osteoarthritis (OA)
Among stem cell type, mesenchymal
segment is expected to hold dominant position in the global stem cell cartilage
regeneration market, owing to growing research and development activities
pertaining to mesenchymal stem cells by various research organizations. For instance,
in November 2018, a peer-reviewed case study conducted using a stem cell
processed by Celltex Therapeutics Corporation, showed improvement in disease
findings following systemic administration of autologous adipose derived
mesenchymal stem cells.
Major players operating in the
global stem cell cartilage regeneration market include Theracell Advanced
Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA,
Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2448
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
